Skip to content

Clinical trials

Phase 3 Urologic Diseases trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Urologic Diseases Phase: Phase 3 Country / region: Germany Clear all

7 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20101
20121
20131
20191
20201
20231

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting3
Completed3
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Astellas Pharma Europe Ltd.2
Novartis Pharmaceuticals2
APOGEPHA Arzneimittel GmbH1
Bioniche Life Sciences Inc.1
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Urologic Diseases7
Kidney Diseases3
Urinary Bladder Diseases3
Urinary Bladder, Overactive3
Urinary Incontinence3
Glomerulonephritis2
Glomerulonephritis, IGA2
Renal Insufficiency, Chronic2
Carcinoma in Situ1
Carcinoma, Transitional Cell1

Trials

Showing 1 to 7 of 7. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.